SOLICITATION NOTICE
A -- HIV Vaccine Design and Development Teams
- Notice Date
- 5/25/2007
- Notice Type
- Solicitation Notice
- NAICS
- 541710
— Research and Development in the Physical, Engineering, and Life Sciences
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions 6700 B Rockledge Room 3214 MSC7612, Bethesda, MD, 20892-7612, UNITED STATES
- ZIP Code
- 00000
- Solicitation Number
- RFP-NIH-NIAID-DAIDS-08-16
- Response Due
- 10/25/2007
- Archive Date
- 11/8/2007
- Description
- The Division of Acquired Immune Deficiency Syndrome (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), is committed to the development of preventive efficacious vaccines against HIV and AIDS for worldwide use in stemming the AIDS epidemic. To augment the vaccine product pipeline, DAIDS is seeking opportunities to advance vaccine concepts toward the product stage via a focused, development-based approach. Specifically, the goal of this Broad Agency Announcement (BAA) is to solicit proposals for the development of new, safe, and immunogenic vaccine candidates that merit further evaluation in large human trials. This solicitation for HIV Vaccine Design and Development Teams (herein referred to as HIV Vaccine Teams) seeks to fund consortia of scientists with product development experience from industry and/or academia who have (1) identified a promising vaccine candidate, and (2) devised a comprehensive strategic research plan for targeted development of the vaccine candidate into a product suitable for testing in humans. It is a requirement of the contract that an HIV Vaccine Team advances the vaccine concept(s) along a well-defined development path in a timely manner to a vaccine product and into clinical testing by the beginning of the fifth year of the award period. Offerors are strongly encouraged, but not required, to conduct phase I/II trials in collaboration with an NIAID/DAIDS-supported clinical trials network, the HIV/AIDS Vaccine Trials Network (the HVTN; http://www.hvtn.org/ ). It is anticipated that one to two (2) cost reimbursement, completion type contracts will be awarded for a period of up to seven (7) years for the base period beginning approximately June 27, 2008. NIH-NIAID-DAIDS-BAA-08-16 will be available electronically on or about June 8, 2007, and may be accessed through on FedBizOpps at http://www.fedbizopps.gov/. This advertisement does not commit the Government to award a contract. Any reasonable offeror may submit a proposal that will be considered by the Government. No collect calls will be accepted. No facsimile transmissions will be accepted. See Government-wide Numbered Note 26.
- Record
- SN01303347-W 20070527/070525220521 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |